Antidepressant prescriptions may reduce the risk of testing positive for COVID-19

FHS
June 21, 2023
3:21 am

New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that community mental health patients who were prescribed antidepressants were significantly less likely to test positive for COVID-19 when admitted to inpatient care.

Rimidi Care Network Launches to Increase Access to Remote Monitoring Services

What You Should Know: Rimidi, a market leading digital health company that supports healthcare providers in the delivery of remote patient monitoring and chronic disease management

March 22, 2024

Heron Therapeutics launches patent suit against Mylan over potential generic for chemo-related nausea

Heron Therapeutics filed suit in Delaware federal court on Friday to block Mylan Pharmaceuticals’ generic version of a drug used for chemotherapy-associated nausea. Heron’s Cinvanti

September 20, 2023

Benefit advice within food banks could help lift people out of poverty

Providing access to housing, debt, and benefit advice within food banks could help lift people out of poverty – according to a University of East

July 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.